nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—EDNRB—type 2 diabetes mellitus	0.233	0.496	CbGaD
MACITENTAN—EDNRA—type 2 diabetes mellitus	0.177	0.376	CbGaD
MACITENTAN—EDNRA—Irbesartan—type 2 diabetes mellitus	0.154	0.385	CbGbCtD
MACITENTAN—CYP3A4—type 2 diabetes mellitus	0.032	0.0681	CbGaD
MACITENTAN—ALB—type 2 diabetes mellitus	0.0279	0.0594	CbGaD
MACITENTAN—ALB—Gliclazide—type 2 diabetes mellitus	0.0226	0.0564	CbGbCtD
MACITENTAN—ALB—Repaglinide—type 2 diabetes mellitus	0.0212	0.053	CbGbCtD
MACITENTAN—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0177	0.0443	CbGbCtD
MACITENTAN—ALB—Valsartan—type 2 diabetes mellitus	0.0156	0.0391	CbGbCtD
MACITENTAN—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0146	0.0366	CbGbCtD
MACITENTAN—ALB—Nateglinide—type 2 diabetes mellitus	0.0145	0.0363	CbGbCtD
MACITENTAN—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0124	0.0311	CbGbCtD
MACITENTAN—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0124	0.0311	CbGbCtD
MACITENTAN—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0115	0.0287	CbGbCtD
MACITENTAN—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0111	0.0277	CbGbCtD
MACITENTAN—ALB—Glyburide—type 2 diabetes mellitus	0.00982	0.0245	CbGbCtD
MACITENTAN—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00933	0.0233	CbGbCtD
MACITENTAN—ALB—Losartan—type 2 diabetes mellitus	0.00898	0.0225	CbGbCtD
MACITENTAN—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00831	0.0208	CbGbCtD
MACITENTAN—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0076	0.019	CbGbCtD
MACITENTAN—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00665	0.0166	CbGbCtD
MACITENTAN—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00637	0.0159	CbGbCtD
MACITENTAN—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00601	0.015	CbGbCtD
MACITENTAN—CYP2C19—Losartan—type 2 diabetes mellitus	0.00582	0.0146	CbGbCtD
MACITENTAN—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00456	0.0114	CbGbCtD
MACITENTAN—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00437	0.0109	CbGbCtD
MACITENTAN—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00437	0.0109	CbGbCtD
MACITENTAN—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00413	0.0103	CbGbCtD
MACITENTAN—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00308	0.00769	CbGbCtD
MACITENTAN—CYP3A4—Losartan—type 2 diabetes mellitus	0.00281	0.00704	CbGbCtD
MACITENTAN—Fluid retention—Chlorpropamide—type 2 diabetes mellitus	0.00161	0.0289	CcSEcCtD
MACITENTAN—Fluid retention—Rosiglitazone—type 2 diabetes mellitus	0.00122	0.0219	CcSEcCtD
MACITENTAN—Nasopharyngitis—Linagliptin—type 2 diabetes mellitus	0.00109	0.0195	CcSEcCtD
MACITENTAN—Fluid retention—Pioglitazone—type 2 diabetes mellitus	0.00102	0.0184	CcSEcCtD
MACITENTAN—Influenza—Nateglinide—type 2 diabetes mellitus	0.000984	0.0177	CcSEcCtD
MACITENTAN—Bronchitis—Nateglinide—type 2 diabetes mellitus	0.000947	0.017	CcSEcCtD
MACITENTAN—Infestation—Linagliptin—type 2 diabetes mellitus	0.000938	0.0168	CcSEcCtD
MACITENTAN—Infestation NOS—Linagliptin—type 2 diabetes mellitus	0.000938	0.0168	CcSEcCtD
MACITENTAN—Urinary tract infection—Linagliptin—type 2 diabetes mellitus	0.000911	0.0164	CcSEcCtD
MACITENTAN—Nasopharyngitis—Rosiglitazone—type 2 diabetes mellitus	0.000833	0.015	CcSEcCtD
MACITENTAN—Bronchitis—Repaglinide—type 2 diabetes mellitus	0.000819	0.0147	CcSEcCtD
MACITENTAN—Angiopathy—Acarbose—type 2 diabetes mellitus	0.000741	0.0133	CcSEcCtD
MACITENTAN—Urinary tract infection—Repaglinide—type 2 diabetes mellitus	0.000738	0.0133	CcSEcCtD
MACITENTAN—Nasopharyngitis—Sitagliptin—type 2 diabetes mellitus	0.000678	0.0122	CcSEcCtD
MACITENTAN—Influenza—Pioglitazone—type 2 diabetes mellitus	0.000675	0.0121	CcSEcCtD
MACITENTAN—Influenza—Glimepiride—type 2 diabetes mellitus	0.000658	0.0118	CcSEcCtD
MACITENTAN—Influenza—Sitagliptin—type 2 diabetes mellitus	0.000656	0.0118	CcSEcCtD
MACITENTAN—Bronchitis—Pioglitazone—type 2 diabetes mellitus	0.000649	0.0117	CcSEcCtD
MACITENTAN—Bronchitis—Sitagliptin—type 2 diabetes mellitus	0.000631	0.0113	CcSEcCtD
MACITENTAN—Nasopharyngitis—Bromocriptine—type 2 diabetes mellitus	0.000614	0.011	CcSEcCtD
MACITENTAN—Infestation NOS—Pioglitazone—type 2 diabetes mellitus	0.000602	0.0108	CcSEcCtD
MACITENTAN—Infestation—Pioglitazone—type 2 diabetes mellitus	0.000602	0.0108	CcSEcCtD
MACITENTAN—Infection—Linagliptin—type 2 diabetes mellitus	0.000594	0.0107	CcSEcCtD
MACITENTAN—Influenza—Bromocriptine—type 2 diabetes mellitus	0.000593	0.0107	CcSEcCtD
MACITENTAN—Urinary tract infection—Pioglitazone—type 2 diabetes mellitus	0.000585	0.0105	CcSEcCtD
MACITENTAN—Infestation—Sitagliptin—type 2 diabetes mellitus	0.000585	0.0105	CcSEcCtD
MACITENTAN—Infestation NOS—Sitagliptin—type 2 diabetes mellitus	0.000585	0.0105	CcSEcCtD
MACITENTAN—Oedema—Acarbose—type 2 diabetes mellitus	0.000581	0.0104	CcSEcCtD
MACITENTAN—Urinary tract infection—Sitagliptin—type 2 diabetes mellitus	0.000568	0.0102	CcSEcCtD
MACITENTAN—Pharyngitis—Glipizide—type 2 diabetes mellitus	0.00056	0.0101	CcSEcCtD
MACITENTAN—Pharyngitis—Pioglitazone—type 2 diabetes mellitus	0.000536	0.00963	CcSEcCtD
MACITENTAN—Pharyngitis—Sitagliptin—type 2 diabetes mellitus	0.000521	0.00935	CcSEcCtD
MACITENTAN—Anaemia—Rosiglitazone—type 2 diabetes mellitus	0.000519	0.00931	CcSEcCtD
MACITENTAN—Oedema—Repaglinide—type 2 diabetes mellitus	0.000485	0.0087	CcSEcCtD
MACITENTAN—Angiopathy—Sitagliptin—type 2 diabetes mellitus	0.000476	0.00855	CcSEcCtD
MACITENTAN—Bronchitis—Gliclazide—type 2 diabetes mellitus	0.000468	0.00841	CcSEcCtD
MACITENTAN—Oedema—Rosiglitazone—type 2 diabetes mellitus	0.000458	0.00822	CcSEcCtD
MACITENTAN—Infection—Rosiglitazone—type 2 diabetes mellitus	0.000455	0.00817	CcSEcCtD
MACITENTAN—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.000449	0.00806	CcSEcCtD
MACITENTAN—Influenza—Orlistat—type 2 diabetes mellitus	0.000442	0.00794	CcSEcCtD
MACITENTAN—Anaemia—Pioglitazone—type 2 diabetes mellitus	0.000435	0.00781	CcSEcCtD
MACITENTAN—Angiopathy—Bromocriptine—type 2 diabetes mellitus	0.000431	0.00774	CcSEcCtD
MACITENTAN—Bronchitis—Valsartan—type 2 diabetes mellitus	0.00043	0.00773	CcSEcCtD
MACITENTAN—EDNRB—islet of Langerhans—type 2 diabetes mellitus	0.000424	0.166	CbGeAlD
MACITENTAN—Anaemia—Glimepiride—type 2 diabetes mellitus	0.000424	0.00761	CcSEcCtD
MACITENTAN—Urinary tract infection—Gliclazide—type 2 diabetes mellitus	0.000422	0.00758	CcSEcCtD
MACITENTAN—Nasopharyngitis—Metformin—type 2 diabetes mellitus	0.000422	0.00757	CcSEcCtD
MACITENTAN—Headache—Tolbutamide—type 2 diabetes mellitus	0.000416	0.00747	CcSEcCtD
MACITENTAN—Influenza—Metformin—type 2 diabetes mellitus	0.000408	0.00732	CcSEcCtD
MACITENTAN—Oedema—Glipizide—type 2 diabetes mellitus	0.000401	0.0072	CcSEcCtD
MACITENTAN—Infestation—Valsartan—type 2 diabetes mellitus	0.000399	0.00717	CcSEcCtD
MACITENTAN—Infestation NOS—Valsartan—type 2 diabetes mellitus	0.000399	0.00717	CcSEcCtD
MACITENTAN—Nasopharyngitis—Irbesartan—type 2 diabetes mellitus	0.000398	0.00715	CcSEcCtD
MACITENTAN—Infestation—Orlistat—type 2 diabetes mellitus	0.000394	0.00708	CcSEcCtD
MACITENTAN—Infestation NOS—Orlistat—type 2 diabetes mellitus	0.000394	0.00708	CcSEcCtD
MACITENTAN—Pharyngitis—Gliclazide—type 2 diabetes mellitus	0.000387	0.00695	CcSEcCtD
MACITENTAN—Influenza—Irbesartan—type 2 diabetes mellitus	0.000385	0.00691	CcSEcCtD
MACITENTAN—Oedema—Pioglitazone—type 2 diabetes mellitus	0.000384	0.0069	CcSEcCtD
MACITENTAN—Urinary tract infection—Orlistat—type 2 diabetes mellitus	0.000383	0.00688	CcSEcCtD
MACITENTAN—Infection—Pioglitazone—type 2 diabetes mellitus	0.000382	0.00685	CcSEcCtD
MACITENTAN—Headache—Tolazamide—type 2 diabetes mellitus	0.000379	0.0068	CcSEcCtD
MACITENTAN—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000379	0.0068	CcSEcCtD
MACITENTAN—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000377	0.00676	CcSEcCtD
MACITENTAN—Headache—Linagliptin—type 2 diabetes mellitus	0.000375	0.00673	CcSEcCtD
MACITENTAN—Infection—Sitagliptin—type 2 diabetes mellitus	0.00037	0.00665	CcSEcCtD
MACITENTAN—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000366	0.00657	CcSEcCtD
MACITENTAN—Infestation NOS—Metformin—type 2 diabetes mellitus	0.000363	0.00653	CcSEcCtD
MACITENTAN—Infestation—Metformin—type 2 diabetes mellitus	0.000363	0.00653	CcSEcCtD
MACITENTAN—EDNRB—retina—type 2 diabetes mellitus	0.000362	0.142	CbGeAlD
MACITENTAN—Influenza—Losartan—type 2 diabetes mellitus	0.000362	0.0065	CcSEcCtD
MACITENTAN—Pharyngitis—Valsartan—type 2 diabetes mellitus	0.000356	0.00638	CcSEcCtD
MACITENTAN—Pharyngitis—Orlistat—type 2 diabetes mellitus	0.000351	0.00631	CcSEcCtD
MACITENTAN—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00035	0.00628	CcSEcCtD
MACITENTAN—Anaemia—Glyburide—type 2 diabetes mellitus	0.000349	0.00627	CcSEcCtD
MACITENTAN—Bronchitis—Losartan—type 2 diabetes mellitus	0.000348	0.00625	CcSEcCtD
MACITENTAN—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000337	0.00606	CcSEcCtD
MACITENTAN—Infection—Bromocriptine—type 2 diabetes mellitus	0.000335	0.00602	CcSEcCtD
MACITENTAN—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.000333	0.00599	CcSEcCtD
MACITENTAN—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000331	0.00594	CcSEcCtD
MACITENTAN—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000325	0.00584	CcSEcCtD
MACITENTAN—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000315	0.00566	CcSEcCtD
MACITENTAN—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000314	0.00563	CcSEcCtD
MACITENTAN—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000314	0.00563	CcSEcCtD
MACITENTAN—Influenza—Ramipril—type 2 diabetes mellitus	0.00031	0.00557	CcSEcCtD
MACITENTAN—Oedema—Glyburide—type 2 diabetes mellitus	0.000309	0.00554	CcSEcCtD
MACITENTAN—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000306	0.00549	CcSEcCtD
MACITENTAN—Headache—Repaglinide—type 2 diabetes mellitus	0.000304	0.00545	CcSEcCtD
MACITENTAN—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000303	0.00543	CcSEcCtD
MACITENTAN—Bronchitis—Ramipril—type 2 diabetes mellitus	0.000298	0.00536	CcSEcCtD
MACITENTAN—EDNRB—pancreas—type 2 diabetes mellitus	0.000298	0.117	CbGeAlD
MACITENTAN—Angiopathy—Metformin—type 2 diabetes mellitus	0.000296	0.00531	CcSEcCtD
MACITENTAN—EDNRB—cortex of kidney—type 2 diabetes mellitus	0.000292	0.114	CbGeAlD
MACITENTAN—Hypotension—Glyburide—type 2 diabetes mellitus	0.000288	0.00518	CcSEcCtD
MACITENTAN—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000288	0.00516	CcSEcCtD
MACITENTAN—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000287	0.00515	CcSEcCtD
MACITENTAN—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000279	0.00502	CcSEcCtD
MACITENTAN—Infection—Gliclazide—type 2 diabetes mellitus	0.000275	0.00494	CcSEcCtD
MACITENTAN—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000272	0.00488	CcSEcCtD
MACITENTAN—EDNRB—adipose tissue—type 2 diabetes mellitus	0.00027	0.106	CbGeAlD
MACITENTAN—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000269	0.00483	CcSEcCtD
MACITENTAN—Angiopathy—Losartan—type 2 diabetes mellitus	0.000263	0.00472	CcSEcCtD
MACITENTAN—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000259	0.00465	CcSEcCtD
MACITENTAN—Oedema—Valsartan—type 2 diabetes mellitus	0.000255	0.00457	CcSEcCtD
MACITENTAN—Infection—Valsartan—type 2 diabetes mellitus	0.000253	0.00454	CcSEcCtD
MACITENTAN—Oedema—Orlistat—type 2 diabetes mellitus	0.000251	0.00452	CcSEcCtD
MACITENTAN—Headache—Glipizide—type 2 diabetes mellitus	0.000251	0.00451	CcSEcCtD
MACITENTAN—Infection—Orlistat—type 2 diabetes mellitus	0.00025	0.00449	CcSEcCtD
MACITENTAN—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00025	0.00448	CcSEcCtD
MACITENTAN—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000248	0.00445	CcSEcCtD
MACITENTAN—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000247	0.00443	CcSEcCtD
MACITENTAN—EDNRA—cortex of kidney—type 2 diabetes mellitus	0.000242	0.0946	CbGeAlD
MACITENTAN—Headache—Pioglitazone—type 2 diabetes mellitus	0.000241	0.00432	CcSEcCtD
MACITENTAN—Hypotension—Valsartan—type 2 diabetes mellitus	0.000238	0.00427	CcSEcCtD
MACITENTAN—Headache—Glimepiride—type 2 diabetes mellitus	0.000234	0.00421	CcSEcCtD
MACITENTAN—Headache—Sitagliptin—type 2 diabetes mellitus	0.000234	0.00419	CcSEcCtD
MACITENTAN—Anaemia—Losartan—type 2 diabetes mellitus	0.000233	0.00419	CcSEcCtD
MACITENTAN—Oedema—Metformin—type 2 diabetes mellitus	0.000232	0.00416	CcSEcCtD
MACITENTAN—Infection—Metformin—type 2 diabetes mellitus	0.00023	0.00413	CcSEcCtD
MACITENTAN—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000227	0.00408	CcSEcCtD
MACITENTAN—EDNRA—adipose tissue—type 2 diabetes mellitus	0.000223	0.0875	CbGeAlD
MACITENTAN—Oedema—Irbesartan—type 2 diabetes mellitus	0.000219	0.00393	CcSEcCtD
MACITENTAN—Infection—Irbesartan—type 2 diabetes mellitus	0.000217	0.0039	CcSEcCtD
MACITENTAN—Hypotension—Metformin—type 2 diabetes mellitus	0.000217	0.00389	CcSEcCtD
MACITENTAN—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000214	0.00385	CcSEcCtD
MACITENTAN—Headache—Bromocriptine—type 2 diabetes mellitus	0.000211	0.0038	CcSEcCtD
MACITENTAN—Oedema—Losartan—type 2 diabetes mellitus	0.000206	0.0037	CcSEcCtD
MACITENTAN—Infection—Losartan—type 2 diabetes mellitus	0.000204	0.00367	CcSEcCtD
MACITENTAN—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000204	0.00367	CcSEcCtD
MACITENTAN—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000202	0.00362	CcSEcCtD
MACITENTAN—Headache—Glyburide—type 2 diabetes mellitus	0.000193	0.00347	CcSEcCtD
MACITENTAN—Hypotension—Losartan—type 2 diabetes mellitus	0.000192	0.00345	CcSEcCtD
MACITENTAN—EDNRB—liver—type 2 diabetes mellitus	0.00019	0.0742	CbGeAlD
MACITENTAN—Oedema—Ramipril—type 2 diabetes mellitus	0.000176	0.00317	CcSEcCtD
MACITENTAN—Headache—Gliclazide—type 2 diabetes mellitus	0.000174	0.00312	CcSEcCtD
MACITENTAN—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000173	0.00311	CcSEcCtD
MACITENTAN—Hypotension—Ramipril—type 2 diabetes mellitus	0.000165	0.00296	CcSEcCtD
MACITENTAN—Headache—Valsartan—type 2 diabetes mellitus	0.000159	0.00286	CcSEcCtD
MACITENTAN—Headache—Orlistat—type 2 diabetes mellitus	0.000158	0.00283	CcSEcCtD
MACITENTAN—Headache—Metformin—type 2 diabetes mellitus	0.000145	0.00261	CcSEcCtD
MACITENTAN—Headache—Irbesartan—type 2 diabetes mellitus	0.000137	0.00246	CcSEcCtD
MACITENTAN—Headache—Losartan—type 2 diabetes mellitus	0.000129	0.00232	CcSEcCtD
MACITENTAN—Headache—Ramipril—type 2 diabetes mellitus	0.000111	0.00199	CcSEcCtD
MACITENTAN—ALB—liver—type 2 diabetes mellitus	8.31e-05	0.0325	CbGeAlD
MACITENTAN—CYP2C19—liver—type 2 diabetes mellitus	6.69e-05	0.0262	CbGeAlD
MACITENTAN—CYP3A4—kidney—type 2 diabetes mellitus	6.26e-05	0.0245	CbGeAlD
MACITENTAN—CYP3A4—liver—type 2 diabetes mellitus	3.95e-05	0.0155	CbGeAlD
MACITENTAN—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	6.95e-06	9.61e-05	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.93e-06	9.59e-05	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	6.91e-06	9.55e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	6.84e-06	9.46e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	6.84e-06	9.46e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	6.82e-06	9.43e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—HK1—type 2 diabetes mellitus	6.81e-06	9.43e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.81e-06	9.42e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	6.74e-06	9.32e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.68e-06	9.24e-05	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	6.67e-06	9.23e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	6.62e-06	9.16e-05	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SRC—type 2 diabetes mellitus	6.59e-06	9.11e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—LPA—type 2 diabetes mellitus	6.58e-06	9.1e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GCKR—type 2 diabetes mellitus	6.58e-06	9.1e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	6.58e-06	9.1e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	6.58e-06	9.1e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	6.53e-06	9.04e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	6.52e-06	9.02e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	6.48e-06	8.97e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	6.48e-06	8.97e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.43e-06	8.9e-05	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.42e-06	8.88e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.37e-06	8.82e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.37e-06	8.82e-05	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	6.34e-06	8.77e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.33e-06	8.75e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	6.31e-06	8.73e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.27e-06	8.68e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	6.22e-06	8.61e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	6.19e-06	8.56e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	6.15e-06	8.5e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.13e-06	8.48e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	6.12e-06	8.46e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.11e-06	8.45e-05	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	6.02e-06	8.32e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.01e-06	8.31e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RELA—type 2 diabetes mellitus	6e-06	8.3e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.94e-06	8.21e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	5.91e-06	8.17e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	5.91e-06	8.17e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	5.91e-06	8.17e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	5.91e-06	8.17e-05	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.89e-06	8.15e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	5.87e-06	8.11e-05	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.77e-06	7.99e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	5.71e-06	7.9e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	5.71e-06	7.9e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.68e-06	7.86e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	5.66e-06	7.84e-05	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.65e-06	7.81e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	5.51e-06	7.63e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	5.51e-06	7.63e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	5.51e-06	7.63e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	5.51e-06	7.63e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.51e-06	7.63e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.5e-06	7.61e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	5.48e-06	7.58e-05	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.46e-06	7.56e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	5.45e-06	7.54e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	5.45e-06	7.53e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.41e-06	7.49e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.39e-06	7.46e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.38e-06	7.44e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—MTR—type 2 diabetes mellitus	5.37e-06	7.42e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	5.37e-06	7.42e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	5.34e-06	7.39e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.33e-06	7.37e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	5.27e-06	7.28e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	5.26e-06	7.28e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.23e-06	7.24e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GCK—type 2 diabetes mellitus	5.23e-06	7.23e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—HBA1—type 2 diabetes mellitus	5.23e-06	7.23e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—LIPC—type 2 diabetes mellitus	5.23e-06	7.23e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	5.2e-06	7.19e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	5.18e-06	7.16e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.11e-06	7.07e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	5.1e-06	7.06e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.06e-06	7e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CETP—type 2 diabetes mellitus	5.04e-06	6.98e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	5.04e-06	6.98e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	5.04e-06	6.98e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.96e-06	6.86e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	4.94e-06	6.84e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	4.94e-06	6.84e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	4.92e-06	6.8e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	4.91e-06	6.8e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	4.82e-06	6.66e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	4.82e-06	6.66e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	4.72e-06	6.53e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SRC—type 2 diabetes mellitus	4.72e-06	6.52e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.7e-06	6.5e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	4.69e-06	6.49e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	4.69e-06	6.49e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	4.69e-06	6.49e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	4.69e-06	6.49e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	4.69e-06	6.49e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	4.69e-06	6.49e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	4.69e-06	6.49e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	4.69e-06	6.49e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	4.69e-06	6.49e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	4.66e-06	6.45e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CTGF—type 2 diabetes mellitus	4.6e-06	6.37e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.59e-06	6.35e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	4.58e-06	6.34e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	4.56e-06	6.31e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	4.53e-06	6.26e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.5e-06	6.22e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	4.49e-06	6.22e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	4.49e-06	6.22e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	4.46e-06	6.18e-05	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6—type 2 diabetes mellitus	4.44e-06	6.14e-05	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	4.41e-06	6.1e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	4.33e-06	5.98e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	4.33e-06	5.98e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	4.29e-06	5.93e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.25e-06	5.88e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	4.24e-06	5.87e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	4.24e-06	5.87e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.22e-06	5.84e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.22e-06	5.83e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	4.21e-06	5.82e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	4.21e-06	5.82e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	4.21e-06	5.82e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.18e-06	5.78e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.18e-06	5.78e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.18e-06	5.78e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	4.14e-06	5.72e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.13e-06	5.72e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.13e-06	5.72e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.12e-06	5.69e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.1e-06	5.67e-05	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.09e-06	5.66e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GCG—type 2 diabetes mellitus	4.07e-06	5.62e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	4.07e-06	5.62e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.04e-06	5.59e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.01e-06	5.54e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.93e-06	5.43e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	3.85e-06	5.33e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	3.81e-06	5.27e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	3.81e-06	5.27e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	3.71e-06	5.14e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.69e-06	5.11e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.68e-06	5.09e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SRC—type 2 diabetes mellitus	3.66e-06	5.06e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.65e-06	5.05e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.65e-06	5.05e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	3.56e-06	4.93e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.55e-06	4.91e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.55e-06	4.91e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.55e-06	4.91e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.55e-06	4.91e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.5e-06	4.85e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GNB3—type 2 diabetes mellitus	3.5e-06	4.85e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	3.49e-06	4.83e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CAT—type 2 diabetes mellitus	3.44e-06	4.76e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.41e-06	4.71e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—APOB—type 2 diabetes mellitus	3.34e-06	4.62e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	3.27e-06	4.52e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	3.25e-06	4.5e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—LPL—type 2 diabetes mellitus	3.19e-06	4.41e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6—type 2 diabetes mellitus	3.18e-06	4.39e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.17e-06	4.38e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.15e-06	4.35e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.15e-06	4.35e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.13e-06	4.33e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.12e-06	4.32e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.11e-06	4.31e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.09e-06	4.27e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.03e-06	4.19e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3e-06	4.15e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	2.99e-06	4.14e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.96e-06	4.09e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.93e-06	4.05e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.92e-06	4.04e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.9e-06	4.01e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.9e-06	4.01e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	2.87e-06	3.97e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.86e-06	3.96e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.84e-06	3.93e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.82e-06	3.9e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.82e-06	3.9e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.82e-06	3.9e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PPARA—type 2 diabetes mellitus	2.82e-06	3.9e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.81e-06	3.88e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.8e-06	3.88e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.79e-06	3.87e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.75e-06	3.81e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—AGT—type 2 diabetes mellitus	2.73e-06	3.78e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.72e-06	3.77e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.72e-06	3.76e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.69e-06	3.72e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CALM1—type 2 diabetes mellitus	2.68e-06	3.71e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—APOE—type 2 diabetes mellitus	2.67e-06	3.7e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—APOA1—type 2 diabetes mellitus	2.64e-06	3.66e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.58e-06	3.57e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.53e-06	3.5e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.53e-06	3.5e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.53e-06	3.5e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.53e-06	3.5e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.49e-06	3.44e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.46e-06	3.41e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.45e-06	3.39e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.41e-06	3.33e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.41e-06	3.33e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.4e-06	3.32e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.37e-06	3.28e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.33e-06	3.22e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.32e-06	3.2e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.29e-06	3.17e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.29e-06	3.17e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—INS—type 2 diabetes mellitus	2.28e-06	3.16e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.27e-06	3.14e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.2e-06	3.04e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.2e-06	3.04e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.09e-06	2.89e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.05e-06	2.84e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2e-06	2.77e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2e-06	2.77e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.89e-06	2.62e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.89e-06	2.62e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.88e-06	2.61e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.88e-06	2.6e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.86e-06	2.57e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.83e-06	2.54e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.8e-06	2.5e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.8e-06	2.49e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.8e-06	2.49e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.75e-06	2.43e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.72e-06	2.38e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.69e-06	2.33e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.68e-06	2.32e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.65e-06	2.28e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.64e-06	2.26e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.62e-06	2.24e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.55e-06	2.15e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.52e-06	2.1e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.47e-06	2.04e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.45e-06	2e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.44e-06	2e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.43e-06	1.97e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.26e-06	1.74e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.23e-06	1.71e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.13e-06	1.56e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.08e-06	1.5e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.08e-06	1.5e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	9.89e-07	1.37e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—AKT1—type 2 diabetes mellitus	9.21e-07	1.27e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	8.27e-07	1.14e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.97e-07	6.88e-06	CbGpPWpGaD
